microRNA target identification by transcriptomics

miRNAtarget 2.0

(Release date: 2022-04-06)

miRNAtarget is a software tool under continuous development for the analysis of the targets of differentially expressed miRNAs.

To perform miRNA-target analyses please signup. Up to twenty (20) miRNAtarget analyses is free of charge for research use. For more than twenty (20) miRNAtarget analyses for research use and for commercial use please inquire about pricing at businessdevelopment @pharmahungary.com.

miRNA-target analysis Previous analyses

Papers published so far on the utilization and validation of the miRNAtarget software

Our team published multiple articles on the utilization and experimental validation of the predictions assessed by the miRNAtarget software:

  1. Schreckenberg R, Klein J, Kutsche HS, Schulz R, Gömöri K, Bencsik P, Benczik B, Ágg B, Sághy É, Ferdinandy P, Schlüter KD.
    Ischaemic Post-Conditioning in Rats: Responder and Non-Responder Differ in Transcriptome of Mitochondrial Proteins.
    J Cell Mol Med. 2020 May;24(10):5528-5541.
  2. Sághy É, Vörös I, Ágg B, Kiss B, Koncsos G, Varga ZV, Görbe A, Giricz Z, Schulz R, Ferdinandy P.
    Cardiac miRNA Expression and Their mRNA Targets in a Rat Model of Prediabetes.
    Int J Mol Sci. 2020 Mar 20;21(6):2128.
  3. Bencsik P, Kiss K, Ágg B, Baán JA, Ágoston G, Varga A, Gömöri K, Mendler L, Faragó N, Zvara Á, Sántha P, Puskás LG, Jancsó G, Ferdinandy P.
    Sensory Neuropathy Affects Cardiac miRNA Expression Network Targeting IGF-1, SLC2a-12, EIF-4e, and ULK-2 mRNAs.
    Int J Mol Sci. 2019 Feb 25;20(4):991.
  4. Ágg B, Baranyai T, Makkos A, Vető B, Faragó N, Zvara Á, Giricz Z, Veres DV, Csermely P, Arányi T, Puskás LG, Varga ZV, Ferdinandy P.
    MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium.
    Sci Rep. 2018 Jul 4;8(1):10134.

Developed by

miRNAtarget was developed in the collaboration of the Pharmahungary Group and the Department of Pharmacology and Pharmacotherapy, Semmelweis University.

Supported by

This study was supported by the National Research, Development and Innovation Office of Hungary (NKFIA; National Heart Program NVKP-16-1-2016-0017).

Contact

If you need technical support please contact [email protected].

Terms and Conditions

Please read Terms and Conditions of the miRNAtarget service.

miRNAtarget 2.0 (release date: 2022-04-06) features

Aims

  • to analyze the targets of miRNAs from a network theoretical perspective
  • to predict the most probable targets of differentially expressed miRNAs

Advantages

  • miRNAtarget relies on multiple miRNA-target interaction databases
  • simple and powerful network theoretical approach to identify the most probable targets of differentially expressed miRNAs
  • increased coverage of possible miRNA-target interactions compared to experimentally validated databases
  • higher accuracy than available predicted miRNA-target interaction databases
  • intuitive relative entropy optimization-based network visualization
  • interactions predicted by miRNAtarget has been successfully validated in multiple animal studies

Recommended for

  • basic researchers
  • small biotech companies
  • pharmaceutical industry
© 2023 Pharmahungary Group
This study was supported by the National Research, Development and Innovation Office of Hungary (NKFIA; National Heart Program NVKP-16-1-2016-0017).

This site uses cookies and in some cases third-party cookies to provide a better experience and service for users. When navigating or using our services you agree to our use of cookies. However, the user has the option to prevent the generation of cookies and disposal of the same by selecting the appropriate option in your browser. If you block the use of cookies on your browser it may disrupt some services and some functions of the website may not be available.

Accept and close